|
Participate in Arthritis Clinical Trials | Arthritis Foundation
Interested in participating in arthritis clinical trials? Learn what to expect from a clinical trial and how you can get involved.
CBD for Arthritis Pain | Arthritis Foundation
Hear more about CBD for arthritis in our Live Yes! With Arthritis Podcast. Our gratitude, once again, to the following experts for their guidance and review: Kevin Boehnke, PhD, a researcher at the Chronic Pain and Fatigue Research Center at the University of Michigan, focuses on medical cannabis as an analgesic and opioid substitute in chronic ...
Investigating rheumatoid arthritis risk factors | Arthritis Foundation
To fill this knowledge gap, the Arthritis Foundation awarded a 2024 Rheumatoid Arthritis Research Program award to Mehmet Hocaoglu, MD, a fellow in the rheumatology and clinical immunology division at the University of Pittsburgh.
Arthritis Research | Arthritis Foundation
Our arthritis research foundation is dedicated to finding a cure for arthritis. Learn about our latest efforts, and find out how to participate in clinical trials.
Featured Clinical Trials - Arthritis Foundation
The Arthritis Foundation is committed to making sure patients are involved in the processes and decisions that affect their health and quality of life, including clinical trials.
2025 Rheumatology Conference Highlights - Arthritis Foundation
By focusing on those populations, clinical trials can be more streamlined. We are currently funding OA trials looking at OA prevention, disease-modifying OA therapies and ways to increase activity after knee replacement surgery to improve quality of life.
Science Highlights 2023 - Arthritis Foundation
On World Arthritis Day, October 12, the Arthritis Foundation announced the launch of the first-ever clinical trial directed and sponsored by the Foundation. It will focus on patients at high risk for post-traumatic osteoarth ritis in the knee. The Post-Injury Knee Arthritis Severity Outcomes (PIKASO) trial is a multi-year, $20 million investment in creating an infrastructure to allow leading research centers to execute randomized clinical trials to test the efficacy of metformin in delaying ...
Osteoarthritis Research Initiatives | Arthritis Foundation
The Arthritis Foundation’s OA program is driving progress in osteoarthritis research by focusing on what matters most: better treatments, earlier intervention and lasting solutions. As the most common form of arthritis in the U.S., osteoarthritis urgently requires innovative approaches to slow or stop disease progression. Through strategic investments in research and clinical trials, the Foundation is identifying high-risk populations, developing tools and techniques for efficient trial ...
Arthritis Foundation to Initiate a Network Model for Clinical Trials
The Arthritis Foundation’s OA-CTN is a $20M infrastructure investment to launch and execute randomized clinical trials in osteoarthritis. July 19, 2023 At least 500 million people globally have clinically diagnosed osteoarthritis and need treatments that can slow or halt disease progression.
Historical Research - Arthritis Foundation
In the 1980s, the AF was behind the earliest clinical trials that set the stage for methotrexate to become a main stay of treatment for RA. An Arthritis Foundation-funded study, “Low dose methotrexate in rheumatoid arthritis,” (K. Steinsson, et al) published in the Journal of Rheumatology in late 1982.
|